STOCK TITAN
  1. Home
  2. Sec-filings
  3. CRWV
  4. [144] CoreWeave, Inc. SEC Filing

CRWV (NASDAQ: CRWV) multiple 10b5-1 sales and 33,330 founders shares listed

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CRWV registers 33,330 shares of Common stock (Founders Shares) under Rule 144. The filing lists numerous 10b5-1 block sales by named holders and trusts on dates in Jan–Apr 2026, including a large 303,929-share sale by Fidelity Charitable on 03/05/2026.

Positive

  • None.

Negative

  • None.
Registered shares 33,330 shares Founders Shares registered under Rule 144
Fidelity Charitable sale 303,929 shares Sale on 03/05/2026 with proceeds $22,930,105.76
Block sale example 300,000 shares 10b5-1 sale on 03/09/2026 by Brannin McBee with proceeds $21,782,820.00
Typical 10b5-1 lot 16,665 shares Repeated 10b5-1 sale size by several holders on multiple dates
10b5-1 Sales regulatory
"10b5-1 Sales for BRANNIN MCBEE ..."
Founders Shares market
"Common | 02/25/2019 | Founders Shares"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
Rule 144 regulatory
"144: Securities To Be Sold"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR

FAQ

What does the CRWV Form 144 register?

The Form 144 registers 33,330 Founders Shares of Common stock. The filing identifies those shares as the securities to be sold and lists multiple historic 10b5-1 sales by various holders in Jan–Apr 2026 as related activity.

Who executed large sales reported in the CRWV filing?

The excerpt shows a notable sale by Fidelity Charitable of 303,929 shares on 03/05/2026. Multiple 10b5-1 sales by Brannin McBee and related trusts also appear across March and April 2026 in the listing.

Are the reported sales part of a trading plan for CRWV?

Yes; several entries are labeled as 10b5-1 Sales, indicating transactions executed under pre-arranged trading plans. The filing lists each sale date, share count, and gross proceeds for those transactions in Jan–Apr 2026.

Does the Form 144 state who receives proceeds from the registered shares?

The filing lists the securities and many resale transactions but does not allocate proceeds within the summary text. The provided lines show gross proceeds per sale entry; recipient treatment beyond those entries is not detailed in this excerpt.